AVDL
Avadel Pharmaceuticals
AVDL
AVDL
59 hedge funds and large institutions have $51M invested in Avadel Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 19 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
63% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 19
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $76K
Holders
59
Holding in Top 10
–
Calls
–
Puts
$76K
Top Buyers
| 1 | +$2.02M | |
| 2 | +$826K | |
| 3 | +$800K | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$468K |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$253K |
Top Sellers
| 1 | -$2.12M | |
| 2 | -$1.98M | |
| 3 | -$1.92M | |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$661K |
| 5 |
CAM
Close Asset Management
London,
United Kingdom
|
-$641K |